GlassScriptPhysician profile
Cassandra N Ramar
NPI 1396032090
$5,592.47
in general payments reported to CMS, 2019-2025
17 companies · $463 in 2025
The $463 reported for 2025 was more than what 79% of Obstetrics & Gynecology providers received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $627 · 2020: $2,461 · 2021: $438 · 2022: $683 · 2023: $578 · 2024: $343 · 2025: $463.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,383.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,383.07 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Intuitive Surgical, INC. | $2,929.73 | 2019-2023 | |
| Hologic Sales and Service, LLC | $621.56 | 2019-2025 | Myosure Tissue Removal Device, Coolseal Generator, Acessa Provu System |
| Aspira Women'S Health INC | $593.81 | 2020-2023 | Ova1 |
| Organon LLC | $324.58 | 2022-2025 | Nexplanon |
| Abbvie INC. | $214.72 | 2019-2023 | |
| Coopersurgical, INC. | $171.29 | 2021-2023 | Summit Doppler |
| Sumitomo Pharma America, INC. | $153.66 | 2023-2024 | Myfembree |
| Organogenesis INC. | $135.35 | 2025 | Puraply Wound Matrix, Apligraf, Affinity |
| Axonics, INC. | $124.46 | 2024 | Bulkamid |
| Therapeuticsmd, INC. | $110.06 | 2019-2022 | |
| Merck Sharp & Dohme LLC | $68.26 | 2019-2023 | Gardasil 9 |
| Astellas Pharma US INC | $44.57 | 2023-2024 | Veozah |
| Bayer Healthcare Pharmaceuticals INC. | $34.25 | 2019-2022 | |
| Pfizer INC. | $19.13 | 2024 | |
| Becton, Dickinson and Company | $18.75 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Exeltis, USA INC. | $16.30 | 2019 | |
| Allergan, INC. | $11.99 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cassandra Ramar listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.